✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

argenx SE

Common Name
argenx
Country
Netherlands
Sector
Healthcare
Industry
Biotechnology
Employees
1,599
Ticker
ARGX
Exchange
EURONEXT
Description
argenx SE is a commercial-stage, global, fully-integrated biopharmaceutical company headquartered in Amsterdam, Netherlands, specializing in the development of differentiated antibody-based therapies ...

Disclosures of argenx

Explore argenx's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from argenx's official channels and fully traceable to its official company sources.

The table below lists all of argenx's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

If you want to search across argenx's' disclosures for specific data or insights, use our Disclosure Search.

NameReporting Period
Annual Report
2024
Annual Report
2023
Annual Report
2023
ESG Report
2023
20-F
2022
Annual Report
2022
ESG Report
2022
20-F
2021
Annual Report
2021
ESG Report
2021
20-F
2020
Annual Report
2020
Annual Report
2019
Annual Report
2019
Annual Report
2018
Annual Report
2018
Annual Report
2017
Annual Report
2017
Annual Report
2016
Annual Report
2015
Annual Report
2014
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?